Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Tarella

Showing results (31-40 of 90) with videos related to

Pageof 9
Sort By:
Haematologica|January 1, 1990
GM-CSF-exposed peripheral blood progenitors as sole source of stem cells for autologous transplantation in two patients with multiple myelomaA Pileri, C Tarella, M Bregni, et al.
Bone Marrow Transplantation|March 24, 1998
G-CSF administration following peripheral blood progenitor cell (PBPC) autograft in lymphoid malignancies: evidence for clinical benefits and reduction of treatment costsC Tarella, C Castellino, F Locatelli, et al.
Journal of the National Cancer Institute|March 21, 1990
Pharmacology and clinical toxicity of 4'-iodo-4'-deoxydoxorubicin: an example of successful application of pharmacokinetics to dose escalation in phase I trialsL Gianni, L Viganò, A Surbone, et al.
Bone Marrow Transplantation|January 10, 2001
Overweight as an adverse prognostic factor for non-Hodgkin's lymphoma patients receiving high-dose chemotherapy and autograftC Tarella, D Caracciolo, P Gavarotti, et al.
Bone Marrow Transplantation|March 24, 1998
A single step density gradient separation for large scale enrichment of mobilized peripheral blood progenitor cells collected for autotransplantationD Ferrero, C Tarella, C Cherasco, et al.
British Journal of Haematology|November 14, 1997
Peripheral blood progenitor cell mobilization in patients with primary refractory lymphoma or at first relapse: comparison with patients at diagnosis and impact on clinical outcomeC Tarella, C Castellino, C Cherasco, et al.
Stem Cells (Dayton, Ohio)|April 24, 1999
Hemopoietic progenitor cell mobilization and harvest following an intensive chemotherapy debulking in indolent lymphoma patientsC Tarella, F Zallio, D Caracciolo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1992
Granulocyte-macrophage colony-stimulating factor or granulocyte colony-stimulating factor infusion makes high-dose etoposide a safe outpatient regimen that is effective in lymphoma and myeloma patientsA M Gianni, M Bregni, S Siena, et al.
Haematologica|January 1, 1990
Use of peripheral blood stem cells to accelerate hemopoietic recovery following autologous bone marrow transplantationC Tarella, P Gavarotti, D Caracciolo, et al.
Bone Marrow Transplantation|August 1, 1990
Durable and complete hematopoietic reconstitution after autografting of rhGM-CSF exposed peripheral blood progenitor cellsA M Gianni, C Tarella, S Siena, et al.
Pageof 9

Showing results (31-40 of 90) with videos related to

Sort By:
Pageof 9
Haematologica|January 1, 1990
GM-CSF-exposed peripheral blood progenitors as sole source of stem cells for autologous transplantation in two patients with multiple myelomaA Pileri, C Tarella, M Bregni, et al.
Bone Marrow Transplantation|March 24, 1998
G-CSF administration following peripheral blood progenitor cell (PBPC) autograft in lymphoid malignancies: evidence for clinical benefits and reduction of treatment costsC Tarella, C Castellino, F Locatelli, et al.
Journal of the National Cancer Institute|March 21, 1990
Pharmacology and clinical toxicity of 4'-iodo-4'-deoxydoxorubicin: an example of successful application of pharmacokinetics to dose escalation in phase I trialsL Gianni, L Viganò, A Surbone, et al.
Bone Marrow Transplantation|January 10, 2001
Overweight as an adverse prognostic factor for non-Hodgkin's lymphoma patients receiving high-dose chemotherapy and autograftC Tarella, D Caracciolo, P Gavarotti, et al.
Bone Marrow Transplantation|March 24, 1998
A single step density gradient separation for large scale enrichment of mobilized peripheral blood progenitor cells collected for autotransplantationD Ferrero, C Tarella, C Cherasco, et al.
British Journal of Haematology|November 14, 1997
Peripheral blood progenitor cell mobilization in patients with primary refractory lymphoma or at first relapse: comparison with patients at diagnosis and impact on clinical outcomeC Tarella, C Castellino, C Cherasco, et al.
Stem Cells (Dayton, Ohio)|April 24, 1999
Hemopoietic progenitor cell mobilization and harvest following an intensive chemotherapy debulking in indolent lymphoma patientsC Tarella, F Zallio, D Caracciolo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1992
Granulocyte-macrophage colony-stimulating factor or granulocyte colony-stimulating factor infusion makes high-dose etoposide a safe outpatient regimen that is effective in lymphoma and myeloma patientsA M Gianni, M Bregni, S Siena, et al.
Haematologica|January 1, 1990
Use of peripheral blood stem cells to accelerate hemopoietic recovery following autologous bone marrow transplantationC Tarella, P Gavarotti, D Caracciolo, et al.
Bone Marrow Transplantation|August 1, 1990
Durable and complete hematopoietic reconstitution after autografting of rhGM-CSF exposed peripheral blood progenitor cellsA M Gianni, C Tarella, S Siena, et al.
Pageof 9